Financials Q-linea AB

Equities

QLINEA

SE0011527845

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm 11:29:41 2024-04-26 am EDT 5-day change 1st Jan Change
3.295 SEK +64.91% Intraday chart for Q-linea AB +59.56% -10.95%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,317 4,592 3,301 306.7 432.3 385 - -
Enterprise Value (EV) 1 990.4 4,261 2,953 233.8 350.4 251.6 379.1 424
P/E ratio -7.43 x -19.7 x -13.8 x -1.14 x -1.06 x -2.71 x -4.02 x -8.24 x
Yield - - - - - - - -
Capitalization / Revenue 1,317 x 3,975 x 337 x 24 x 97.4 x 6.36 x 2.31 x 2.38 x
EV / Revenue 990 x 3,689 x 302 x 18.3 x 78.9 x 4.16 x 2.27 x 2.62 x
EV / EBITDA -5.66 x -19.8 x -13.1 x -0.95 x -1.64 x -1.45 x -2.92 x -6.24 x
EV / FCF -5.58 x -17 x -10.6 x - -1.48 x -1.7 x -5.49 x -6.06 x
FCF Yield -17.9% -5.88% -9.44% - -67.4% -58.8% -18.2% -16.5%
Price to Book 3.86 x 12.1 x 7.66 x 1.88 x 2.28 x 1.68 x 3.58 x -
Nbr of stocks (in thousands) 22,907 27,009 29,209 29,209 116,838 116,838 - -
Reference price 2 57.50 170.0 113.0 10.50 3.700 3.295 3.295 3.295
Announcement Date 2/13/20 2/18/21 2/17/22 2/16/23 2/27/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1 1.155 9.785 12.79 4.44 60.55 166.8 162
EBITDA 1 -175 -215.4 -226.2 -247 -213.1 -173.6 -129.7 -68
EBIT 1 -179.1 -221.5 -233.6 -262.2 -230.6 -189.2 -147.2 -90
Operating Margin -17,910% -19,181.21% -2,386.82% -2,050.73% -5,193.4% -312.4% -88.25% -55.56%
Earnings before Tax (EBT) 1 -177.4 -218.7 -231.2 -268.7 -229.4 -190.8 -146.4 -87
Net income 1 -177.4 -218.7 -231.2 -268.7 -229.4 -190.8 -146.4 -80
Net margin -17,740% -18,931.17% -2,363.23% -2,101.14% -5,165.9% -315.09% -87.73% -49.38%
EPS 2 -7.740 -8.640 -8.190 -9.200 -3.480 -1.215 -0.8200 -0.4000
Free Cash Flow 1 -177.4 -250.5 -278.9 - -236.3 -148 -69 -70
FCF margin -17,739.2% -21,691.17% -2,849.96% - -5,321.78% -244.43% -41.36% -43.21%
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 - - - - - - - -
Announcement Date 2/13/20 2/18/21 2/17/22 2/16/23 2/27/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 0.022 1.358 2.998 0.061 2.2 4 10 15
EBITDA 1 -58.04 -60.11 -43.83 -51.06 -39 -32 -26 -25
EBIT 1 -62.24 -64.61 -48.25 -55.45 -44 -36 -31 -30
Operating Margin -282,927.27% -4,757.51% -1,609.51% -90,900% -2,000% -900% -310% -200%
Earnings before Tax (EBT) - - - - - - - -
Net income - - - - - - - -
Net margin - - - - - - - -
EPS - - -0.5600 -0.8200 - - - -
Dividend per Share - - - - - - - -
Announcement Date 5/4/23 7/13/23 11/2/23 2/27/24 - - - -
1SEK in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - 39
Net Cash position 1 327 331 348 72.9 81.9 133 5.88 -
Leverage (Debt/EBITDA) - - - - - - - -0.5735 x
Free Cash Flow 1 -177 -251 -279 - -236 -148 -69 -70
ROE (net income / shareholders' equity) -41.5% -60.6% -57% -90.5% -130% -65.2% -82.6% -189%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 14.90 14.10 14.80 5.590 1.620 1.960 0.9200 -
Cash Flow per Share - - - - - - - -
Capex 1 7.63 13.2 12 17.2 7.77 16.4 19.4 20
Capex / Sales 763.2% 1,145.28% 122.34% 134.88% 174.91% 27.14% 11.65% 12.35%
Announcement Date 2/13/20 2/18/21 2/17/22 2/16/23 2/27/24 - - -
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Quarterly revenue - Rate of surprise